Evidence map›Paper›PMID 42397008›Full record

ArticleJournal of cell science2026

FAM122A inhibition of PP2A-B55 through a bipartite binding mechanism.

Iker Benavides-Puy, Suzanne Vigneron, Arminja N Kettenbach, Thierry Lorca, Jakob Nilsson

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Iker Benavides-PuyCenter for Epigenetic Cell Memory, Danish Cancer Institute, 2100 Copenhagen, Denmark.
Suzanne VigneronUniversité de Montpellier, Centre de Recherche en Biologie cellulaire de Montpellier (CRBM), CNRS UMR 5237, 1919 Route de Mende, 34293 Montpellier cedex 5, France.
Arminja N KettenbachDepartment of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, NH 03755, USA.
Thierry LorcaUniversité de Montpellier, Centre de Recherche en Biologie cellulaire de Montpellier (CRBM), CNRS UMR 5237, 1919 Route de Mende, 34293 Montpellier cedex 5, France.
Jakob NilssonCenter for Epigenetic Cell Memory, Danish Cancer Institute, 2100 Copenhagen, Denmark.ORCID 0000-0003-4100-1125

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Danish Cancer Society R269-A15586-B71Danish National Research Foundation DNRF195Det frie forskningsråd - Natur og Univers 4283-00188BNational Institute of General Medicine Sciences R35GM119455NCI NIH HHS P30CA023108Novo Nordisk Fonden NNF0065098Novo Nordisk Fonden NNF0082227Novo Nordisk Foundation NNF0065098Novo Nordisk Foundation NNF0082227Novo Nordisk Foundation NNF14CC0001
6 · The paper itself

Abstract

FAM122A (also known as PABIR1) regulates cell cycle progression through inhibition of the PP2A-B55 phosphoprotein phosphatase. Recent structural work has uncovered helical elements in the N-terminus of FAM122A as binding determinants for PP2A-B55 but whether FAM122A inhibition towards PP2A-B55 is regulated is presently unclear. To address this, we performed a systematic analysis of the PP2A-B55 interaction with FAM122A in cells uncovering a novel region in the C-terminus of FAM122A, spanning residues 150-170, required for binding. This C-terminal region and the N-terminal helices are both required for efficient binding to PP2A-B55 suggesting a bipartite binding mechanism. We perform amino acid resolution scans of FAM122A 150-170 uncovering several residues in this region contributing to binding including the conserved Ser158, a reported phosphorylation site. We show that Ser158 is important for PP2A-B55 inhibition in human cells as well as efficient stimulation of mitotic entry in Xenopus laevis egg extracts. In human cells and in Xenopus laevis Ser158 phosphorylation is regulated, with increased occupancy correlating with cell cycle stages requiring PP2A-B55 inhibition. Collectively our work uncovers novel aspects of the FAM122A interaction with PP2A-B55 and provides a possible mechanism for how the inhibitory activity of FAM122A can be regulated during the cell cycle.

Indexed as

Protein Phosphatase 2Amino Acid SequenceAnimalsCell CycleHeLa CellsHumansPhosphorylationProtein BindingXenopus laevisProtein Phosphatase 2Cell cycleFAM122APhosphorylationPP2A-B55

Identifiers

PMID42397008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.